Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 409 to 415 of 415 entries
Sorted by: Best Match Show Resources per page
Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study.

European review for medical and pharmacological sciences

Schianchi A, Ughi N, Cassano G, Del Gaudio F, Dicuonzo A, Scaglione F, Alberti PM, Rossetti C, Micheloni G, Zoppini L, Bellavia G, Giroldi S, Moreno M, Russo A, Bosio M, Epis OM.
PMID: 34919220
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7218-7222. doi: 10.26355/eurrev_202112_27414.

OBJECTIVE: Anti-COVID-19 vaccines were mainly associated with non-serious adverse events (AEs), whose prevalence was reported to be up to 70% in healthcare workers (HCWs). This may lead to sick leave requests, but this impact has never been quantified. This...

Cite
Schianchi A, Ughi N, Cassano G, et al. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. Eur Rev Med Pharmacol Sci. 2021;25(23):7218-7222doi: 10.26355/eurrev_202112_27414.
Schianchi, A., Ughi, N., Cassano, G., Del Gaudio, F., Dicuonzo, A., Scaglione, F., Alberti, P. M., Rossetti, C., Micheloni, G., Zoppini, L., Bellavia, G., Giroldi, S., Moreno, M., Russo, A., Bosio, M., & Epis, O. M. (2021). Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. European review for medical and pharmacological sciences, 25(23), 7218-7222. https://doi.org/10.26355/eurrev_202112_27414
Schianchi, A, et al. "Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study." European review for medical and pharmacological sciences vol. 25,23 (2021): 7218-7222. doi: https://doi.org/10.26355/eurrev_202112_27414
Schianchi A, Ughi N, Cassano G, Del Gaudio F, Dicuonzo A, Scaglione F, Alberti PM, Rossetti C, Micheloni G, Zoppini L, Bellavia G, Giroldi S, Moreno M, Russo A, Bosio M, Epis OM. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study. Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7218-7222. doi: 10.26355/eurrev_202112_27414. PMID: 34919220.
Copy Download .nbib Format: NLM
Usefulness of digital measurements for functional evaluation of paediatric elbow range of motion.

Journal of telemedicine and telecare

Magno GM, Fleman C, Halliburton C, Bosio S, Puigdevall MH.
PMID: 33938305
J Telemed Telecare. 2021 May 02;1357633X211001731. doi: 10.1177/1357633X211001731. Epub 2021 May 02.

BACKGROUND: Elbow immobilization due to fractures of the upper limb is frequent in paediatric patients. Proper follow-up is critical to assess elbow functional recovery. Telemedicine can be an option for remote monitoring of these patients. The purpose of this...

Cite
Magno GM, Fleman C, Halliburton C, et al. Usefulness of digital measurements for functional evaluation of paediatric elbow range of motion. J Telemed Telecare. 2021;1357633X211001731doi: 10.1177/1357633X211001731.
Magno, G. M., Fleman, C., Halliburton, C., Bosio, S., & Puigdevall, M. H. (2021). Usefulness of digital measurements for functional evaluation of paediatric elbow range of motion. Journal of telemedicine and telecare, 1357633X211001731. https://doi.org/10.1177/1357633X211001731
Magno, Gonzalo M, et al. "Usefulness of digital measurements for functional evaluation of paediatric elbow range of motion." Journal of telemedicine and telecare vol. (2021): 1357633X211001731. doi: https://doi.org/10.1177/1357633X211001731
Magno GM, Fleman C, Halliburton C, Bosio S, Puigdevall MH. Usefulness of digital measurements for functional evaluation of paediatric elbow range of motion. J Telemed Telecare. 2021 May 02;1357633X211001731. doi: 10.1177/1357633X211001731. Epub 2021 May 02. PMID: 33938305.
Copy Download .nbib Format: NLM
Skeletal Divergence and Condylar Asymmetry in Patients with Temporomandibular Disorders (TMD): A Retrospective Study.

BioMed research international

Sfondrini MF, Bolognesi L, Bosco M, Gandini P, Scribante A.
PMID: 34608439
Biomed Res Int. 2021 Sep 24;2021:8042910. doi: 10.1155/2021/8042910. eCollection 2021.

INTRODUCTION: This study was aimed at evaluating the association between vertical skeletal patterns, condylar height symmetry, and temporomandibular disorders in adults.METHODS: The study sample consisted of 200 patients (ages 18-30 years old) retrospectively recruited: 100 with temporomandibular disorders (TMD)...

Cite
Sfondrini MF, Bolognesi L, Bosco M, et al. Skeletal Divergence and Condylar Asymmetry in Patients with Temporomandibular Disorders (TMD): A Retrospective Study. Biomed Res Int. 2021;2021:8042910doi: 10.1155/2021/8042910.
Sfondrini, M. F., Bolognesi, L., Bosco, M., Gandini, P., & Scribante, A. (2021). Skeletal Divergence and Condylar Asymmetry in Patients with Temporomandibular Disorders (TMD): A Retrospective Study. BioMed research international, 20218042910. https://doi.org/10.1155/2021/8042910
Sfondrini, Maria Francesca, et al. "Skeletal Divergence and Condylar Asymmetry in Patients with Temporomandibular Disorders (TMD): A Retrospective Study." BioMed research international vol. 2021 (2021): 8042910. doi: https://doi.org/10.1155/2021/8042910
Sfondrini MF, Bolognesi L, Bosco M, Gandini P, Scribante A. Skeletal Divergence and Condylar Asymmetry in Patients with Temporomandibular Disorders (TMD): A Retrospective Study. Biomed Res Int. 2021 Sep 24;2021:8042910. doi: 10.1155/2021/8042910. eCollection 2021. PMID: 34608439; PMCID: PMC8487372.
Copy Download .nbib Format: NLM
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome.

Neurobiology of disease

Bartolucci ML, Berteotti C, Alvente S, Bastianini S, Guidi S, Lo Martire V, Matteoli G, Silvani A, Stagni F, Bosi M, Alessandri-Bonetti G, Bartesaghi R, Zoccoli G.
PMID: 34509609
Neurobiol Dis. 2021 Nov;159:105508. doi: 10.1016/j.nbd.2021.105508. Epub 2021 Sep 10.

STUDY OBJECTIVES: The use of mouse models in sleep apnea study is limited by the belief that central (CSA) but not obstructive sleep apneas (OSA) occur in rodents. We aimed to develop a protocol to investigate the presence of...

Cite
Bartolucci ML, Berteotti C, Alvente S, et al. Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome. Neurobiol Dis. 2021;159:105508doi: 10.1016/j.nbd.2021.105508.
Bartolucci, M. L., Berteotti, C., Alvente, S., Bastianini, S., Guidi, S., Lo Martire, V., Matteoli, G., Silvani, A., Stagni, F., Bosi, M., Alessandri-Bonetti, G., Bartesaghi, R., & Zoccoli, G. (2021). Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome. Neurobiology of disease, 159105508. https://doi.org/10.1016/j.nbd.2021.105508
Bartolucci, Maria Lavinia, et al. "Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome." Neurobiology of disease vol. 159 (2021): 105508. doi: https://doi.org/10.1016/j.nbd.2021.105508
Bartolucci ML, Berteotti C, Alvente S, Bastianini S, Guidi S, Lo Martire V, Matteoli G, Silvani A, Stagni F, Bosi M, Alessandri-Bonetti G, Bartesaghi R, Zoccoli G. Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome. Neurobiol Dis. 2021 Nov;159:105508. doi: 10.1016/j.nbd.2021.105508. Epub 2021 Sep 10. PMID: 34509609.
Copy Download .nbib Format: NLM
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.

Cell

Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lopès A, Johnson SB, Schwarz B, Bohrnsen E, Cogdill AP, Bosio CM, Wargo JA, Lee MP, Goldszmid RS.
PMID: 34624222
Cell. 2021 Oct 14;184(21):5338-5356.e21. doi: 10.1016/j.cell.2021.09.019. Epub 2021 Oct 07.

The tumor microenvironment (TME) influences cancer progression and therapy response. Therefore, understanding what regulates the TME immune compartment is vital. Here we show that microbiota signals program mononuclear phagocytes in the TME toward immunostimulatory monocytes and dendritic cells (DCs)....

Cite
Lam KC, Araya RE, Huang A, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184(21):5338-5356.e21doi: 10.1016/j.cell.2021.09.019.
Lam, K. C., Araya, R. E., Huang, A., Chen, Q., Di Modica, M., Rodrigues, R. R., Lopès, A., Johnson, S. B., Schwarz, B., Bohrnsen, E., Cogdill, A. P., Bosio, C. M., Wargo, J. A., Lee, M. P., & Goldszmid, R. S. (2021). Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell, 184(21), 5338-5356.e21. https://doi.org/10.1016/j.cell.2021.09.019
Lam, Khiem C, et al. "Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment." Cell vol. 184,21 (2021): 5338-5356.e21. doi: https://doi.org/10.1016/j.cell.2021.09.019
Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lopès A, Johnson SB, Schwarz B, Bohrnsen E, Cogdill AP, Bosio CM, Wargo JA, Lee MP, Goldszmid RS. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021 Oct 14;184(21):5338-5356.e21. doi: 10.1016/j.cell.2021.09.019. Epub 2021 Oct 07. PMID: 34624222; PMCID: PMC8650838.
Copy Download .nbib Format: NLM
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.

Schizophrenia research

Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M.
PMID: 34839071
Schizophr Res. 2021 Nov 25;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25.

BACKGROUND: Although remission is a priority target in psychosis, reported rates show a marked variation across studies and instability over time. Such variability, partly due to methodology, emphasizes the need to define the optimal assessment procedure, as well as...

Cite
Carpiniello B, Pinna F, Manchia M, et al. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021;239:34-41doi: 10.1016/j.schres.2021.11.023.
Carpiniello, B., Pinna, F., Manchia, M., Tusconi, M., Cavallaro, R., & Bosia, M. (2021). Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophrenia research, 23934-41. https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello, Bernardo, et al. "Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study." Schizophrenia research vol. 239 (2021): 34-41. doi: https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021 Nov 25;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25. PMID: 34839071.
Copy Download .nbib Format: NLM
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.

Schizophrenia research

Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M.
PMID: 34839071
Schizophr Res. 2022 Jan;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25.

BACKGROUND: Although remission is a priority target in psychosis, reported rates show a marked variation across studies and instability over time. Such variability, partly due to methodology, emphasizes the need to define the optimal assessment procedure, as well as...

Cite
Carpiniello B, Pinna F, Manchia M, et al. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021;239:34-41doi: 10.1016/j.schres.2021.11.023.
Carpiniello, B., Pinna, F., Manchia, M., Tusconi, M., Cavallaro, R., & Bosia, M. (2022). Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophrenia research, 23934-41. https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello, Bernardo, et al. "Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study." Schizophrenia research vol. 239 (2022): 34-41. doi: https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2022 Jan;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25. PMID: 34839071.
Copy Download .nbib Format: NLM
Showing 409 to 415 of 415 entries